Clinical Trial

Air-in-Line Alarms During Antineoplastic Drug Infusion

Study acronym: AIR-ONC
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to evaluate infusion alarms, particularly air-in-line alarms, during antineoplastic drug infusion in oncology care settings. The main questions it aims to answer are: How frequently do infusion alarms occur, and what types of alarms are observed during antineoplastic drug infusion? How long does it take healthcare professionals to manage infusion alarms and restore infusion continuity? What strategies do healthcare professionals use to manage infusion alarms? How do healthcare professionals evaluate the user experience of different infusion technologies? Participants will be healthcare professionals involved in antineoplastic drug infusion. They will not receive any experimental intervention. Researchers will observe routine infusion procedures and collect data on alarm events, alarm management, infusion technologies, and user experience.
Trial Details
NCT Number NCT07718711
Lead Sponsor Associazione Italiana Infermieri di Area Oncologica
Collaborators: IRCCS Multimedica, University of Milan
Conditions Infusion Safety, Medication Safety, Antineoplastic Drug Administration, Air-in-Line Alarm
Enrollment 40 participants
Start Date 2026-07-01
Primary Completion 2028-06-01 (estimated)
Study Completion 2028-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-22